피나스테라이드: 프로페시아,핀페시아,프로스카,핀카등 전세계 피나스테리드계열 제네릭의약품 정보.

두타스테라이드: 아보다트, 제네릭아보다트 정보/ 미녹시딜정 : 먹는 미녹시딜 / 스피로놀락톤:알닥톤,스피로닥톤

미녹시딜 5%액 : 로게인,리게인, 잔드록스,마이녹실,스칼프메드등 minoxidil계열의 정보

기타의약품:시메티딘,로아큐탄,스티바A(트레티노인),다이안느, 드로겐정, 판토가

지난 주 댓글 랭킹

1등 탈모용사
2등 탈모는극복하는것
3등 앙흥
4등 K4817292865
5등 K42611233062505142351

6등 K5068773496
7등 ssing
8등 두랩
9등 K5072365620
10등 K4850826266

[두타스테리드] 두타스레이트 새소식..(번역은 안했습니다..ㅡ.ㅡ.)

23년 전
1,441

Dutasteride On Track For Release in 2002

Jean-Pierre Garnier
September 18, 2002 - Dr Garnier, the Chief Executive Officer of GlaxoSmithKline, gave a presentation at the Bear Stearns Healthcare Conference in New York today. Approximately 250 investors and portfolio managers were in attendance for the presentation. Dr Garnier discussed highlights of GSK's strategy for building the best pipeline in the industry.

In the presentation he confirmed the release of 11 new drugs over the next 2 years including Dutasteride. Glaxo is waiting for FDA approval of their 2 year study data before marketing Dutasteride which is expected to happen somewhere near the end of 2002.

On July 25, 2002 GlaxoSmithKline announced that it had received approval from the Swedish regulatory authority (MPA) for Dutasteride to be sold in Sweden, and thereby opening the door for it to be marketed in the whole of Europe.

Chart showing how much DHT Dutasteride inhibits in contrast to Finasteride (Propecia)

P.S 음..0.5mg으로 90%정도의 DHT감소라..대단하군요..
탈모치료제로서 얼마만큼의 양이 적정량이냐.....참..어렵습니다...ㅡ.ㅡ...
0.5mg만..되도 탈모치료에선 떡을치고도 남을 양인거 만은 분명해보입니다..
어쨌든...탈모치료제로서 좀 더 확실한 자료들이 나와야죠..
전립선치료제로 나온다면 의사들은 거의 99%이상 처방안해줄테니 말이죠..ㅡ.ㅡ..

진짜무삭발+진짜모낭줄기세포=모디헤어플란트